DYSF Gene Limb-girdle muscular dystrophy autosomal recessive type 2B Genetic Test
Overview
The DYSF gene is associated with Limb-girdle muscular dystrophy, autosomal recessive type 2B (LGMD2B), a genetic disorder characterized by progressive muscle weakness and wasting primarily affecting the muscles of the shoulders and hips.
Test Details
The DYSF Gene Limb-girdle muscular dystrophy autosomal recessive type 2B Genetic Test is a Neurological Disorders genetic test offered by DNA Labs UAE. The test utilizes NGS (Next-Generation Sequencing) technology to analyze multiple genes simultaneously.
Components and Price
- Test Name: DYSF Gene Limb-girdle muscular dystrophy autosomal recessive type 2B Genetic Test
- Price: 4400.0 AED
Sample Condition
The test requires either a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery
The test results are typically delivered within 3 to 4 weeks.
Method
The test utilizes NGS technology for analysis.
Test Type
The test is specifically designed for Neurological Disorders.
Doctor and Test Department
The test is conducted by a Neurologist and falls under the Genetics department.
Pre Test Information
Prior to the test, a clinical history of the patient is required. Additionally, a Genetic Counselling session is conducted to draw a pedigree chart of family members affected with DYSF Gene Limb-girdle muscular dystrophy, autosomal recessive type 2B.
Understanding NGS Genetic Testing for LGMD2B
NGS genetic testing is a comprehensive method that allows for the identification of mutations or variations in the DYSF gene associated with LGMD2B. The test involves obtaining a DNA sample, usually through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any variations or mutations in the DYSF gene. This information can help confirm a diagnosis of LGMD2B and provide details about the specific genetic variant causing the condition.
Carrier Testing
NGS genetic testing can also be used for carrier testing. Carrier testing identifies individuals who carry one copy of a gene mutation associated with a genetic disorder. This can be particularly useful for individuals with a family history of LGMD2B who want to determine if they are at risk of passing the condition on to their children.
Important Note
It’s important to note that NGS genetic testing is a complex process that requires specialized laboratory facilities and expertise. The results of the test should be interpreted by a healthcare professional or genetic counselor who can provide appropriate guidance and counseling based on the individual’s specific situation.
| Test Name | DYSF Gene Limb-girdle muscular dystrophy autosomal recessive type 2B Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for DYSF Gene Limb-girdle muscular dystrophy, autosomal recessive type 2B NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with DYSF Gene Limb-girdle muscular dystrophy, autosomal recessive type 2B |
| Test Details | The DYSF gene is associated with Limb-girdle muscular dystrophy, autosomal recessive type 2B (LGMD2B), which is a genetic disorder characterized by progressive muscle weakness and wasting primarily affecting the muscles of the shoulders and hips. NGS (Next-Generation Sequencing) genetic testing refers to a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of LGMD2B, NGS genetic testing can be used to identify mutations or variations in the DYSF gene that are associated with the condition. NGS genetic testing for LGMD2B typically involves obtaining a DNA sample, usually through a blood sample or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any variations or mutations in the DYSF gene. This can help in confirming a diagnosis of LGMD2B and providing information about the specific genetic variant causing the condition. NGS genetic testing can also be used for carrier testing, which is the identification of individuals who carry one copy of a gene mutation associated with a genetic disorder. This can be useful for individuals who have a family history of LGMD2B and want to know if they are at risk of passing the condition on to their children. It’s important to note that NGS genetic testing is a complex process that requires specialized laboratory facilities and expertise. The results of the test should be interpreted by a healthcare professional or genetic counselor who can provide appropriate guidance and counseling based on the individual’s specific situation. |
